GKB Ophthalmics (BOM:533212) Total Equity: ₹549 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:533212 GKB Ophthalmics Ltd BOM:533212
63 GF Score
Price ₹59.46
GF Value ₹162.30
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is GKB Ophthalmics Total Equity?

GKB Ophthalmics BOM:533212 +3.79% 63 Total Equity is ₹549 Mil as of Mar. 2026. GuruFocus rates BOM:533212 with a GF Score™ of 63/100 and a GF Value™ of ₹162.30 (Possible Value Trap). The stock has 4 warning signs investors should review.

GKB Ophthalmics's total equity for the quarter that ended in Mar. 2026 was ₹549 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

GKB Ophthalmics Total Equity Historical Data

* Premium members only.

The historical data trend for GKB Ophthalmics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GKB Ophthalmics Total Equity Chart

GKB Ophthalmics Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 674.16 672.97 642.03 564.37 548.88

GKB Ophthalmics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 564.37 0.00 572.45 0.00 548.88
BOM:533212
63GF Score
GKB Ophthalmics Ltd BOM:533212
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GKB Ophthalmics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

GKB Ophthalmics's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=1321.664-772.785
=549

GKB Ophthalmics's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=1321.664-772.785
=549

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹549 Mil mean?
GKB Ophthalmics (BOM:533212) has a Total Equity of ₹549 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for GKB Ophthalmics and its competitors.
Is GKB Ophthalmics' Total Equity too high?
GKB Ophthalmics' current Total Equity is ₹549 Mil. Overall, GKB Ophthalmics has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does GKB Ophthalmics' Total Equity compare to ISRG and BDX?
GKB Ophthalmics' Total Equity of ₹549 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for GKB Ophthalmics and its competitors. GKB Ophthalmics's current Total Equity is ₹549 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GKB Ophthalmics stock overvalued right now?
Based on GuruFocus' analysis, GKB Ophthalmics (BOM:533212) is currently considered Possible Value Trap. The stock's GF Value™ is ₹162.30, compared to a current price of ₹59.46 — trading 63.4% below its estimated fair value. The current Total Equity is ₹549 Mil. GKB Ophthalmics' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For GKB Ophthalmics (BOM:533212), the current Total Equity is ₹549 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GKB Ophthalmics (BOM:533212) Overvalued in 2026?

Based on GuruFocus' analysis, GKB Ophthalmics stock appears to be undervalued. The current stock price of ₹59.46 is trading 63.4% below its estimated GF Value™ of ₹162.30. GuruFocus considers GKB Ophthalmics to be Possible Value Trap.

Key valuation signals for BOM:533212:

  • Total Equity: ₹549 Mil
  • GF Value™: ₹162.30 vs. price of ₹59.46 (63.4% below fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the BOM:533212 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GKB Ophthalmics Business Description

Address 16-A, Tivim Industrial Estate, Mapusa, GA, IND, 403 526
GKB Ophthalmics Ltd is an India-based company engaged in manufacturing and exporting ophthalmics lenses. It manufactures glass and plastic lenses both semi-finished and finished forms. The other products of the company include Organic lenses, Glass moulds, and Bifocal moulds. The company sells its products in India and also exports globally. Geographically, the majority of its revenue is generated from outside of India.
63GF Score

Get the complete analysis for BOM:533212

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹59.46
Price
₹162.30
GF Value